Sabinsa’s C3 Reduct® is the only reductive metabolites of curcuminoids on the market approved as a Novel Food by EFSA. Easy to integrate into existing production processes with the concentrated benefits of curcuminoids, C3 Reduct® has been shown to boost organ health and sports nutrition delivering a range of targeted functionalities.
Find out how C3 Reduct® can help you meet consumer health/wellness expectations and open new market opportunities by downloading the white paper.
© HPCi Media Limited | Registered in England No. 6716035 | Natraj Building The Tanneries, 55 Bermondsey St, London SE1 3XG | VAT GB 939828072